key: cord-0990446-1itm7v2e authors: Tian, X.; Zhang, Y.; Wang, W.; Fang, F.; Zhang, W.; Wan, Y.; Zhu, Z. title: Comprehensive analyses reveal the impacts of vaccination status and physiological variables in early infection on viral persistence in COVID-19 patients: a retrospective single-center cohort study date: 2022-04-18 journal: nan DOI: 10.1101/2022.04.14.22273860 sha: 0fc775887d0f83a944bddaf8a2587bc2b155048e doc_id: 990446 cord_uid: 1itm7v2e BACKGROUND: Viral persistence is a crucial factor that influences the communicability of SARS-CoV-2 infection. However, the impacts of vaccination status and physiological variables on viral RNA shedding have not been adequately clarified. METHODS: In this study, we retrospectively collected the clinical records of 377 hospitalized COVID-19 patients, which contained unvaccinated patients and patients received two doses of an inactivated vaccine or an mRNA vaccine. Firstly, we analyzed the impacts of vaccination on disease severity and viral RNA persistence. Next, to clarify the impacts of physiological variables on viral RNA shedding in COVID-19 patients, we retrieved 49 laboratory variables and analyzed their correlations with the duration of viral RNA shedding. Finally, we established a multivariate regression model to predict the duration of viral RNA shedding. RESULTS: Our results showed that both inactivated and mRNA vaccines significantly reduced the rate of moderate cases, while the vaccine related shortening of viral RNA shedding were only observed in moderate patients. Correlation analysis showed that 10 significant laboratory variables were shared by the unvaccinated mild patients and mild patients inoculated with an inactivated vaccine, but not by the mild patients inoculated with an mRNA vaccine. Moreover, we demonstrated that a multivariate regression model established based on the variables correlating with viral persistence in unvaccinated mild patients could predict the duration of viral shedding for all groups of patients. CONCLUSIONS: Vaccination contributed limitedly to the clearance viral RNA in COVID-19 patients. While, laboratory variables in early infection could predict the persistence of viral RNA. Real world studies suggest that the implementing of vaccination have 57 dramatically reduced the rates of SARS-CoV-2 infection and SARS-CoV-2 58 related hospitalization, admission to intensive care unit and death (1-3). In CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 5 of 2019-nCoV are ≤ 37 and the amplification curve is "S-shaped", the result is 116 defined as positive. When the Ct values of both genes are > 40 or 117 undetermined, the result is defined as negative. When the Ct value is between 118 37~40, the sample would be re-examined. Vaccines reduced the proportion of the moderate cases and shortened 143 the duration of viral RNA shedding among moderate COVID-19 patients 144 In this study, we retrospectively retrieved the clinical records of 377 COVID-19 145 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Figure 1A ). More interestingly, we found that patients inoculated with an 160 inactivated vaccine showed significantly shorter duration of viral RNA shedding 161 in moderate patients compared with unvaccinated patients (17, IQR 162 12.25-19.5 vs 19, IQR 12-24.5, P=0.0382) and patients inoculated with an 163 mRNA vaccine (17, P=0 .0385) ( Figure 1B ). However, the vaccines showed no effect in constraining the duration of viral 165 RNA shedding in mild COVID-19 patients ( Figure 1C ). CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273860 doi: medRxiv preprint 7 relevant to the duration of viral RNA shedding in the mild COVID-19 patients, 176 we performed correlation analyses between the duration of viral RNA shedding 177 and 49 laboratory variables detected at the immediate early stage of infection. Our data showed that 16 variables in unvaccinated patients ( Figure 2A CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. Multiple factors have been found to associate with prolonged viral RNA 235 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; 9 shedding in previous studies, such as old age (19) shedding in these patients. Second, although a previous study showed that 294 viral RNA load (>10 7 copies/ml) is an independent risk factor for live virus 295 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; 13 Household . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; negative predictive value; PPV, positive predictive value. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 18, 2022. ; https://doi.org/10.1101/2022.04.14.22273860 doi: medRxiv preprint Note: Data conforming to the normal distribution are shown as mean ± standard deviation (SD), and data not conforming to the normal distribution are shown as the median (IQR). Abbreviations: ALT, glutamic pyruvic transaminase; AST, glutamic oxalo-acetic transaminase; ALP, alkaline phosphatase; L-γ-GGT, gamma glutamyl transferase; LDH, lactate dehydrogenase; TBil, total bilirubin; DBil, Direct Bilirubin; Alb, albumin; globulin; SCr, serum creatinine; Glu, glucose; UA, uric acid; eGFR, estimated glomerular filtering rate; INR, international normalized ratio; PTA, prothrombin activity prothrombin time activity; PT, Prothrombin Effectiveness and safety of SARS-CoV-2 vaccine in real-world 348 studies: a systematic review and meta-analysis Real-world effectiveness of 350 COVID-19 vaccines: a literature review and meta-analysis Real world effectiveness of covid-19 vaccines Effect of Vaccination 355 on Transmission of SARS-CoV-2 Effect of Vaccination on 14 Isolation To Evaluate Potential Infectivity of Clinical Specimens Tested for COVID-19 Viral Cultures for Coronavirus Disease 390 2019 Infectivity Assessment: A Systematic Review N terminal pro B type natriuretic peptide; CK Isoenzyme, creatine kinase isoenzyme; ESR, erythrocyte sedimentation rate Supplementary figure 2 Individual variables could not reliably discriminate between short (≤14 days) and long (>14 days) duration of viral RNA shedding for unvaccinated mild COVID-19 patients. Univariate regression analyses showed that each of the significant variables identified in the correlation analyses could not confidently discriminate between short (≤14 days) and long (>14 days) duration of viral RNA shedding for the unvaccinated mild COVID-19 patients.